Master protocol

Peptide reconstitution, end to end.

Lyophilized research peptides arrive as a freeze-dried powder cake. Before any in vitro work, the cake must be dissolved in a sterile solvent. The reconstitution step is straightforward when done correctly and irrecoverable when done wrong. Here is the full protocol researchers use.

What you need before starting

Reconstitution requires four items: the lyophilized peptide vial, a sealed multi-dose vial of bacteriostatic water (sterile water with 0.9% benzyl alcohol), a sterile insulin syringe with a 27-30 gauge needle, and an alcohol prep pad for cleaning vial septums.

Bacteriostatic water is the standard solvent because the 0.9% benzyl alcohol prevents microbial growth across the typical four-week working window once the vial is opened. Sterile water without preservative is suitable only for single-use applications because reuse after opening introduces contamination risk.

Choose a syringe size that matches your typical research dose volume. For most protocols, a 1 mL syringe with 100-unit (0.01 mL) gradations gives sufficient precision. Researchers working with very small doses sometimes use 0.5 mL syringes for finer measurement.

Step-by-step reconstitution procedure

Bring both vials to room temperature before starting. Cold solvent added to a cold peptide cake can produce slower dissolution and minor handling difficulties. Five minutes on the counter is sufficient.

Clean the rubber septum of both vials with an alcohol prep pad. Let the alcohol air-dry rather than wiping it off, which would re-introduce surface contamination.

Calculate your reconstitution volume. For a 5 mg vial reconstituted with 2 mL, the working concentration is 2.5 mg/mL and each 0.1 mL contains 0.25 mg. For a 10 mg vial reconstituted with 2 mL, the concentration is 5 mg/mL and each 0.1 mL contains 0.5 mg. Match the volume to your typical research dose so per-administration volumes are easy to measure.

Draw the planned volume of bacteriostatic water into the syringe. Invert the BWFI vial during the draw so the needle stays submerged in liquid rather than pulling air bubbles.

Inject the bacteriostatic water slowly down the inside wall of the lyophilized peptide vial. Do not inject directly into the cake — this can cause aerosolization and material loss. The solvent should run down the wall and settle around the cake.

Swirl the vial gently with a small circular motion. Do not shake. Shaking introduces shear stress that can denature peptide bonds and reduce assay potency. A clear, particle-free solution should result within thirty to sixty seconds.

Once dissolved, the working solution is ready to use. Label the vial with the date of reconstitution and the working concentration.

Why we swirl and not shake

Peptide bonds are sensitive to shear stress. Vigorous shaking introduces high-velocity collisions between molecules and the air-liquid interface, which can denature secondary and tertiary structure. The result is a reduction in biologically active peptide compared to the labeled amount.

Swirling produces gentle laminar flow that dissolves the lyophilized cake without introducing shear. Even for compounds that appear forgiving (such as smaller, more stable peptides), swirling is the safer technique because it produces no opportunity for shear-induced denaturation.

If the cake does not fully dissolve within sixty seconds of swirling, wait another minute and swirl again. Persistent undissolved material may indicate a higher-than-expected peptide concentration or a slow-dissolving form — adding 0.5 mL more bacteriostatic water and re-swirling usually resolves it.

Dose math and volume calculation

After reconstitution, the working concentration is (peptide mass) divided by (solvent volume). For a 5 mg vial with 2 mL of BWFI, the math is 5 ÷ 2 = 2.5 mg/mL.

To compute the volume for a target dose: (target dose in mg) divided by (working concentration in mg/mL) equals the volume in mL. For a 250 microgram (0.25 mg) target dose at 2.5 mg/mL: 0.25 ÷ 2.5 = 0.1 mL.

Insulin syringes measure in units. The standard conversion is 100 units = 1 mL. So 0.1 mL is 10 units on the syringe. Most research protocols can be measured cleanly in 5-10 unit increments.

Pre-compute the volume math for your typical dose ranges before reconstitution. This avoids math errors during the actual research preparation and lets you confirm that your chosen reconstitution volume produces a working concentration with practical syringe measurements.

Storage of reconstituted solution

Once reconstituted, store the working solution at 36–46°F (2–8°C). Most lyophilized peptides remain stable in solution for twenty-eight days under refrigeration with bacteriostatic water as the diluent.

Avoid the refrigerator door, where temperature fluctuates with each open-close cycle. The middle of a refrigerator shelf, away from the door and away from the back wall (where freezing can occur on poorly calibrated units), is the most stable location.

If your research protocol extends beyond four weeks, reconstitute fresh batches rather than extending a single working solution. The 28-day window is conservative; some peptides remain stable longer, but degradation accelerates beyond that point and varies by compound.

Repeated freeze-thaw cycles damage reconstituted peptides. If freezing aliquots for long-term storage is required, divide the solution into single-use volumes before the first freeze and thaw each aliquot only once.

Sterile technique and contamination prevention

Bacteriostatic water prevents growth of contaminant bacteria, but it is not bactericidal. If a contaminant is introduced in sufficient quantity, it can persist in the solution. Sterile technique on every draw is essential.

Always clean the septum with alcohol before each needle insertion. Use a fresh needle for each draw — never reinsert a used needle into a sterile vial. Avoid touching the needle to any non-sterile surface before insertion.

Inspect each draw for cloudiness, particulates, or color change. A reconstituted peptide solution should remain clear throughout the working window. Any visible change suggests contamination and the vial should be discarded.

Frequently asked questions

Can I use sterile water instead of bacteriostatic water?

Only for single-use applications. Sterile water has no preservative, so any opened vial is vulnerable to microbial contamination on subsequent draws. For multi-dose research where the same peptide vial is used across multiple preparations, bacteriostatic water is the correct choice.

How long can I keep the reconstituted solution?

Twenty-eight days under refrigeration at 36–46°F (2–8°C). Mark the reconstitution date on the vial and discard after 28 days even if liquid remains. Some peptides remain stable longer, but the 28-day window is the conservative standard for the bacteriostatic preservation system.

Why does the cake not fully dissolve on the first swirl?

Some peptides dissolve more slowly than others. Wait sixty seconds, swirl again, and check. If material remains undissolved after two minutes total, adding 0.5 mL more bacteriostatic water and re-swirling usually resolves it. The final concentration math should be recomputed against the new total volume.

Is it dangerous to shake the vial?

Not dangerous in the safety sense, but it reduces peptide potency. Shaking introduces shear stress that can denature peptide bonds. The resulting solution may contain less active peptide than the label indicates. Swirling is the safer technique with no downside.

Can I store unopened lyophilized vials at room temperature?

Short term (days to weeks) at room temperature is acceptable for most lyophilized peptides. Long-term storage (months to years) should be at 0°F (−18°C). Refrigeration (36-46°F) is acceptable for medium-term storage of unopened vials when freezer space is limited.

References

1. United States Pharmacopeial Convention (2020). Bacteriostatic Water for Injection — USP Monograph. View source
2. Akers MJ (2014). Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality. View source
3. Manning MC, Chou DK, Murphy BM, et al. (2010). Stability of protein pharmaceuticals: an update. View source